In addition, studies focusing on gene expression of AP1S3 that encodes σ1C revealed that it is highly expressed in TNBC, glioma, and pancreatic ductal adenocarcinoma (PDAC) [16–18], suggesting high expression of AP-1 complex in these cancers. This evidence concerns the gene AP1S3 and central nervous system cancer.